Cargando…
ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification
Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-angiotensin system, provides protection against several chronic diseases. Besides chronic diseases, ACE2 is the host receptor for SARS-CoV or SARS-CoV-2 virus, mediating the first step of virus infection. ACE2 levels are regula...
Autores principales: | Wang, Chia-Wen, Chuang, Huai-Chia, Tan, Tse-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464117/ https://www.ncbi.nlm.nih.gov/pubmed/37608279 http://dx.doi.org/10.1186/s12929-023-00965-9 |
Ejemplares similares
-
SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
por: Chuang, Huai‐Chia, et al.
Publicado: (2022) -
Regulation of ACE-2 enzyme by hyperoxia in lung epithelial cells by post-translational modification
por: Mohamed, Tarek, et al.
Publicado: (2021) -
Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability
por: Chen, Hsueh-Fen, et al.
Publicado: (2019) -
MAP4K4 and IL-6(+) Th17 cells play important roles in non-obese type 2 diabetes
por: Chuang, Huai-Chia, et al.
Publicado: (2017) -
MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus
por: Chuang, Huai-Chia, et al.
Publicado: (2019)